Get started
Author

Emi Tanaka

ORCID: 0000-0002-0456-2882
Observed ORCID: 0000-0002-0456-2882
OpenAlex ID: A5064663235
Promising Gene Therapy Using an Adenovirus Vector Carrying REIC/Dkk-3 Gene for the Treatment of Biliary Cancer
2020 · Emi Tanaka, Daisuke Uchida, et al. · Current Gene Therapy · 12
Dipeptide γ‑secretase inhibitor treatment enhances the anti‑tumor effects of cisplatin against gastric cancer by suppressing cancer stem cell properties
2018 · Ryo Kato, Masaya Iwamuro, et al. · Oncology Letters · 5
PDF
Borderline Resectable Classification Identifies Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab
2026 · Yasuto Takeuchi, Masahiko Sue, et al. · Hepatology Research · 2
PDF
Pancreatic Exocrine Insufficiency in Intraductal Papillary Mucinous Carcinoma Presenting with Leg Edema Treated with Pancreatic Exocrine Replacement Therapy
2021 · Emi Tanaka, Tsuneyoshi Ogawa, et al. · Internal Medicine · 2
PDF
Cancer of Unknown Primary Presenting with Chylothorax
2024 · Emi Tanaka, Naohiro Oda, et al. · Internal Medicine · 1
Japanese Spotted Fever Associated with Mild Encephalitis/Encephalopathy with a Reversible Splenial Lesion
2022 · Emi Tanaka, Naohiro Oda, et al. · Internal Medicine · 1
PDF
Mediastinal Lymph Node Metastasis of Esophageal Cancer with Esophageal Stenosis Diagnosed via Transesophageal Endoscopic Ultrasound with Bronchoscope-guided Fine-needle Aspiration
2021 · Emi Tanaka, Naohiro Oda, et al. · Internal Medicine · 1
PDF
Usefulness of the Lymphocyte-to-Monocyte Ratio in Predicting Prognosis in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
2026 · Emi Tanaka, Toshifumi Tada, et al. · Oncology
Prognostic Impact of Gastrointestinal Immune-Related Adverse Events Depends on Nutritional Status in Cancer Patients Treated with Immune Checkpoint Inhibitors
2025 · Shoichiro Hirata, Yoshiyasu Kono, et al. · Cancers
PDF
Works count: 9
Citation count: 24
H-index: 2
I10-index: 1
Year
Topic
Type